Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Edema With Central Retinal Vein Occlusions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02169648
What this trial is testing

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein OcclusionCentral Retinal Vein Occlusion
Tokyo Medical University 100
Post-approval studies (Phase 4)Study completedNCT05832996
What this trial is testing

Cool vs Room-temperature Artificial Tears

Who this might be right for
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)Central Retinal Vein Occlusion With Macular EdemaExudative Age-Related Macular Degeneration, Unspecified Eye+4 more
University of Iowa 124
Large-scale testing (Phase 3)Study completedNCT00105027
What this trial is testing

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Who this might be right for
Macular Edema, CystoidRetinal Vein Occlusion
The Emmes Company, LLC 682
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Large-scale testing (Phase 3)Study completedNCT01377597
What this trial is testing

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 47
Large-scale testing (Phase 3)Study completedNCT04976777
What this trial is testing

Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina

Who this might be right for
Macular Edema
AbbVie 54
Post-approval studies (Phase 4)Study completedNCT06708637
What this trial is testing

Ocular Safety and Usability Study for FYB203 PFS

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion with Macular EdemaCentral Retinal Vein Occlusion with Macular Edema+2 more
Formycon AG 30
Not applicableStudy completedNCT04812977
What this trial is testing

Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Hayatabad Medical Complex 30
Large-scale testing (Phase 3)Study completedNCT01599650
What this trial is testing

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)Study completedNCT04290195
What this trial is testing

Use of Ziv Aflibercept in Different Retinal Diseases

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Amin El Sayed Nawar 55
Testing effectiveness (Phase 2)Study completedNCT02006147
What this trial is testing

Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO

Who this might be right for
Central Retinal Vein Occlusion With Macular EdemaBranch Retinal Vein Occlusion With Macular Edema
Taiwan Liposome Company 14
Early research (Phase 1)Study completedNCT02867735
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 28
Early research (Phase 1)Ended earlyNCT00969293
What this trial is testing

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Fovea Pharmaceuticals SA 11
Large-scale testing (Phase 3)Study completedNCT04740931
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein OcclusionHemiretinal Vein Occlusion
Hoffmann-La Roche 729
Early research (Phase 1)Ended earlyNCT03790852
What this trial is testing

Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

Who this might be right for
Wet Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Kodiak Sciences Inc 121
Testing effectiveness (Phase 2)UnknownNCT01123564
What this trial is testing

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
University of Pecs 40
Not applicableStudy completedNCT04847895
What this trial is testing

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 5,500
Early research (Phase 1)Study completedNCT01028248
What this trial is testing

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
California Retina Consultants 20
Post-approval studies (Phase 4)Study completedNCT01870427
What this trial is testing

NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions

Who this might be right for
Macular Edema With Central Retinal Vein Occlusions
Northern California Retina Vitreous Associates 20
Testing effectiveness (Phase 2)Study completedNCT02571972
What this trial is testing

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Who this might be right for
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more
Wills Eye 14
Next Page